DYAI
Dyadic International IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$27.37M
P/E Ratio
—
EPS
$-0.22
Beta
1.17
52W High
$1.35
52W Low
$0.66
50-Day MA
$0.82
200-Day MA
$0.93
Dividend Yield
—
Profit Margin
-238.30%
Forward P/E
6.84
PEG Ratio
0.00
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces and sells enzymes and other proteins in the United States. The company is headquartered in Jupiter, Florida.
Fundamentals
| Revenue (TTM) | $3.09M |
| Gross Profit (TTM) | 770,480 |
| EBITDA | — |
| Operating Margin | -269.60% |
| Return on Equity | -397.80% |
| Return on Assets | -44.90% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $0.03 |
| Price-to-Book | 23.36 |
| Price-to-Sales (TTM) | 8.86 |
| EV/Revenue | 21.53 |
| EV/EBITDA | -2.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -30.80% |
| Shares Outstanding | $36.44M |
| Float | $27.08M |
| % Insiders | 25.47% |
| % Institutions | 15.95% |
Historical Volatility
HV 10-Day
59.39%
HV 20-Day
47.12%
HV 30-Day
91.91%
HV 60-Day
82.45%
HV Rank
89.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026